Recruiting Amyloidosis Studies in Milwaukee
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
Immunoglobulin light chain (AL) amyloidosis is the most common form of systemic amyloidosis. AL amyloidosis has many root causes and is characterized by the overproduction of AL that are secreted by c...
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
The purpose of this study is assess safety, safest dose, and effectiveness of venetoclax in combination with dexamethasone in participants with t(11;14) positive relapsed (comes back) or refractory (d...
About Amyloidosis Clinical Trials in Milwaukee
Amyloidosis is a group of diseases in which abnormal proteins (amyloids) build up in organs and tissues, impairing their function. Types include AL, AA, and ATTR amyloidosis. Treatment depends on the type and may include chemotherapy, organ transplant, or targeted therapies.
There are currently 2 amyloidosis clinical trials recruiting participants in Milwaukee, WISCONSIN. These studies are seeking a combined 129 participants. Research is being sponsored by AbbVie, Rajshekhar Chakraborty, MD. Clinical trial participation is free and participants receive study-related medical care at no cost.
Amyloidosis Clinical Trials in Milwaukee — FAQ
Are there amyloidosis clinical trials in Milwaukee?
Yes, there are 2 amyloidosis clinical trials currently recruiting in Milwaukee, WISCONSIN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Milwaukee?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Milwaukee research site will contact you about next steps.
Are clinical trials in Milwaukee free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Milwaukee studies also compensate for your time and travel.
What amyloidosis treatments are being tested?
The 2 active trials in Milwaukee are testing new therapies including novel drugs, biologics, and treatment approaches for amyloidosis.
Data updated March 2, 2026 from ClinicalTrials.gov